Revenue
2024
2025
2026
Exascale Labs Holdings Inc. (XLAB)
Price$4.50Cached quote
Financial statements
| 2026 | 2025 | 2024 | |
|---|---|---|---|
| Revenue | $14.8M | $7.0M | $1.3M |
| Gross profit | $2.4M | $1.1M | $55,567 |
| Gross margin | 16.31% | 15.75% | 4.21% |
| Research & development | $5.5M | $2.8M | $1.4M |
| Operating expenses | $7.2M | $4.2M | $1.9M |
| Operating income | −$4.8M | −$3.0M | −$1.8M |
| Operating margin | −32.39% | −43.40% | −139.93% |
| EBITDA | −$4.8M | −$3.0M | −$1.8M |
| EBITDA margin | −32.34% | −43.31% | −139.62% |
| Net income | −$12.2M | −$7.7M | −$5.0M |
| Net profit margin | −82.05% | −109.18% | −375.73% |
| Basic EPSper basic share | -$8,108.26 | -$5,106.44 | -$0.08 |
| Diluted EPSper diluted share | -$8,108.26 | -$5,106.44 | -$0.08 |
Owners
Reported shareholders